The performance review of SKIMS revealed various financial and operational deficiencies like under-utilisation of funds and irregular withdrawals, State Principal Accountant General (Audit) Subhash Chandra Pandey told reporters while releasing the CAG report here today.
The report said the institute did not have any approved long term master or perspective plan for phased and planned infrastructure development and for purchase of medical equipment or civil infrastructure.
Also Read
The report said the infrastructure development was not planned properly as the works targeted for completion by 2010-11 were incomplete besides seven schemes for which Rs 8.51 crores had been credited to civil deposit head were not taken up for execution.
"The advance centre for human genetics and local area networking systems could not be established in the institute due to improper planning despite investment of Rs 12.12 crore," the report said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
